1onf: Difference between revisions

Revision as of 13:30, 28 July 2008

This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.

File:1onf.png

Template:STRUCTURE 1onf

Crystal structure of Plasmodium falciparum Glutathione reductaseCrystal structure of Plasmodium falciparum Glutathione reductase

Template:ABSTRACT PUBMED 12729762

About this StructureAbout this Structure

1ONF is a Single protein structure of sequence from Plasmodium falciparum. Full crystallographic information is available from OCA.

ReferenceReference

Glutathione reductase of the malarial parasite Plasmodium falciparum: crystal structure and inhibitor development., Sarma GN, Savvides SN, Becker K, Schirmer M, Schirmer RH, Karplus PA, J Mol Biol. 2003 May 9;328(4):893-907. PMID:12729762

Page seeded by OCA on Mon Jul 28 13:30:34 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-[[Image:1onf.jpg|left|200px]]
+{{Seed}}
+[[Image:1onf.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_1onf|  PDB=1onf  |  SCENE=  }}
-'''Crystal structure of Plasmodium falciparum Glutathione reductase'''
+===Crystal structure of Plasmodium falciparum Glutathione reductase===
-==Overview==
+<!--
-The malarial parasite Plasmodium falciparum is known to be sensitive to oxidative stress, and thus the antioxidant enzyme glutathione reductase (GR; NADPH+GSSG+H(+) &lt;==&gt; NADP(+)+2 GSH) has become an attractive drug target for antimalarial drug development. Here, we report the 2.6A resolution crystal structure of P.falciparum GR. The homodimeric flavoenzyme is compared to the related human GR with focus on structural aspects relevant for drug design. The most pronounced differences between the two enzymes concern the shape and electrostatics of a large (450A(3)) cavity at the dimer interface. This cavity binds numerous non-competitive inhibitors and is a target for selective drug design. A 34-residue insertion specific for the GRs of malarial parasites shows no density, implying that it is disordered. The precise location of this insertion along the sequence allows us to explain the deleterious effects of a mutant in this region and suggests new functional studies. To complement the structural comparisons, we report the relative susceptibility of human and plasmodial GRs to a series of tricyclic inhibitors as well as to peptides designed to interfere with protein folding and dimerization. Enzyme-kinetic studies on GRs from chloroquine-resistant and chloroquine-sensitive parasite strains were performed and indicate that the structure reported here represents GR of P.falciparum strains in general and thus is a highly relevant target for drug development.
+The line below this paragraph, {{ABSTRACT_PUBMED_12729762}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 12729762 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_12729762}}
 ==About this Structure==
@@ Line 30: / Line 34: @@
 [[Category: Schirmer, R H.]]
 [[Category: Oxidoreductase]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May  3 04:03:52 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 13:30:34 2008''